STX-1200

N/A

Report date: 2025/09/15 16:03:50

Base Information

Drug NameSTX-1200
Drug Alias NameSTX-1200
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionApolipoprotein(a) modulators
TargetsApolipoprotein(a)
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScribe Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesScribe Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A